Redeye maintains its positive view on Optomed after the Q1 report. As expected, the global lockdown had a negative impact on camera revenues, which will become even more pronounced in Q2. However, we think that revenues are postponed, and not lost, and expect them to pick up again in Q3 and especially in Q4.